Patent · US Active

Angiogenesis using placental stem cells

US9254302B2 · kind B2 · utility

1Cited by

171References

20Claims

0Family size

Assignee

Anthrogenesis Corporation · US

Inventors

Stewart Abbot · Hackettstown, US
James W. Edinger · Belford, US
Aleksandar Francki · Santa Monica, US
Robert J. Hariri · New York, US
Vladimir Jankovic · New York, US
Aleksandr Kaplunovsky · Budd Lake, US
Kristen Labazzo · Springfield, US
Eric Law · Florham Park, US
Neerav D. PADLIYA · Scotch Plains, US
Jennifer Paredes · Florham Park, US
Jia-Lun Wang · Cherry Hill, US

Key dates

Filing date	Apr 6, 2011
Grant date	Feb 9, 2016
Priority date	—
Expiry date	Nov 2, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N5/0605
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.